Trial intelligence / Profile preview

Guanfacine for PONV and Pain After Sinus Surgery

NCT02882854Completed

Sponsor
Vanderbilt University Medical Center
Start
Nov 2016
Primary completion
Feb 2017
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial in postoperative nausea and vomiting (PONV) and postoperative pain comparing Guanfacine with Placebo (2 arms). Primary endpoint: Postoperative Nausea and Vomiting Score (nVRS) at 24 hours. Started Nov 2016; status: completed.

02

Drugs

guanfacine
03

Conditions

postoperative nausea and vomiting (PONV)postoperative pain

Beyond the preview

Go deeper on NCT02882854.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02882854.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call